Dangote Foundation, GBCHealth, join forces to build Coalition on Health
NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Dangote Foundation (www.Dangote.com) and GBCHealth have joined forces to forge a new model of partnership, African Business Coalition on Health (GBCHealth) in Africa.
Chairman of Dangote Foundation, Aliko Dangote, shared plans to build an African Business Coalition on Health (ABCHealth), during the Bloomberg Global Business Forum, he was co-hosting, and which took place alongside the United Nations General Assembly this week in New York.
According to him, the African-led coalition of companies and philanthropists, will seek to improve the health and wellbeing of Africans, both within the workplace and within the broader communities. He stated that the partnership will develop and deploy impactful health programs across Africa, deepening knowledge, building evidence for future investment and strengthening coordination among African philanthropists, business leaders, companies and local business networks.
The Coalition is building on the leadership, reputation and convening power of the Aliko Dangote Foundation and the experience, reputation and global reach of GBCHealth. Critical issues that will be the focus of the partnership ranges from nutrition to malaria, with priorities identified and agreed by local leadership.
Through his Foundation, Dangote has made an unprecedented grant and seed contribution to GBCHealth of US$ 1.5 million over three years as a call to action and a signal to the African business community of the importance of working together and investing in health.
"The time is ripe for the private sector to proactively demonstrate its value in partnering to lead a new era in development," said Mr. Dangote. "The coalition can provide much needed guidance to ensure activities and investments are driving results in areas where the private sector can have real impact, focusing on holistic and integrated solutions that cross borders. We look forward to working with other business leaders as partners in development to drive this impact."
Co-chair of GBCHealth's Board of Directors, Aigboje Aig-Imoukhuede said, "This coalition brings together two heavyweights in the health and development arena."
"Together we have an opportunity to demonstrate how investing in health and creating healthier populations, can help business maximize shareholder value, accelerate economic growth and make entry into new markets more feasible."
The coalition will have five primary objectives over its first three years:
Incubate partnerships on priority health programs to enhance and accelerate results;
- Work directly with companies to optimize workplace and community health programs;
- Advocate for policies and initiatives that drive system-level changes;
- Create a hub of data and insights specific to Africa and African business;
- Curate leadership events to convene and drive action around common health issues, across sectors.
The program will kick off in Nigeria and roll out through business regions in Africa and beyond over the next three years.
The continent currently has 400 companies with revenue of more than $1 billion per year, and these companies are growing faster, and are more profitable in general, than their global peers. Coupled with these fast-moving regional leaders, small and growing businesses create 80% of the continent's employment and are stoking the engines of growth.
Against this backdrop, according to Dangote, there's a new cadre of responsible business leaders and philanthropists who understand the value and promise of sustainable large-scale investments in African countries, and are poised to make an even bigger impact on the continent's people and economies.
Investments in better training, healthcare and supply chain accountability have demonstrated direct financial return through gains in productivity and efficiency, while support for social programs has accelerated economic growth and raised incomes which in turn unlocks a wider consumer base and makes entry into new markets more feasible.
In her comments, CEO of the Dangote Foundation, Zouera Youssoufou, said, "GBCHealth has a strong track record of bringing diverse groups together to improve the health wellbeing of communities. We look forward to collaborating to build an African business community united as a force for healthier and more inclusive development."
"What is needed now is an approach that combines the value of local insights and trusted networks with the leverage of a global platform and expertise to support the more coordinated and impactful involvement of the African private sector across the continent and within the global development community," commented Mr. Aig-Imoukhuede.
"The coalition builds on the local-to-global business approach we have developed in Nigeria through our work with the Corporate Alliance on Malaria in Africa (CAMA). The Aliko Dangote Foundation has demonstrated expertise in implementing result-oriented health programs in Nigeria and across Africa. We look forward to our collaboration to bring insights from this work to a global audience," said Nancy Wildfeir-Field, President of GBCHealth.
Immediate plans include hiring an African based CEO for ABCHealth, and building a support base for the coalition working towards a launch in early 2018.
The foundation is generously providing office space and support for coalition staff over the first three years of development.
"It's an ambitious and bold project," said Dangote, "but the only way to move Africa forward is to take bold moves, to think big, dream big and do big things together - breaking down silos, working across borders and working across sectors- with government and with each other."
Distributed by APO on behalf of Dangote Group.
+234 806 630 4898
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Dangote Group via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Tier1CRM Receives Significant Equity Capital to Accelerate Growth11.12.2017 23:28 | Pressemelding
Raises $34 Million (USD) from Leading Financial and Strategic Investors to Continue Building on Recent Successes TORONTO and NEW YORK, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Tier1CRM (Tier1), a provider of cloud-based customer relationship management (CRM) solutions for the capital markets industry, announced today that it raised $34 million (USD) in growth equity financing from a group of investors led by Wavecrest Growth Partners, with participation from MassMutual Ventures and Salesforce Ventures. Founded in 2008 by Mark Notten and Phil Dias and based in Toronto, Tier1 is a leading provider of CRM and customer engagement SaaS solutions to sell-side and buy-side financial services clients spanning sales and trading desks, investment banks and investment managers. Major global financial institutions leverage the Tier1 platform to efficiently and more profitably manage client relationships, improve internal transparency and collaboration, manag
Minerva Neurosciences Names Richard Russell President11.12.2017 22:40 | Pressemelding
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the appointment of Rick Russell as President. Dr. Remy Luthringer will continue as Chief Executive Officer of Minerva while resigning his position as President. Mr. Russell has more than 20 years of experience leading commercial operations, including developing and implementing sales and marketing activities for major biotechnology and pharmaceutical brands in North America and the European Union. His experience encompasses several therapeutic areas, including CNS disorders, neurodegenerative disorders, cardiovascular disease and women's health. "We welcome Rick Russell to Minerva, where his wide-ranging commercial expertise will help ensure the effective transition from late-stage clinical development to the market for our product c
Sonoco-Alcore to Increase Paperboard Prices in Europe11.12.2017 22:30 | Pressemelding
BRUSSELS, Belgium, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Sonoco-Alcore S.a.r.l. today announced it will again raise prices by a further €50 per tonne on all recycled paperboard grades sold in the Company's Central European regions. The price change is effective with shipments on or after the 1st January 2018. "The continued strong demand for core board across Europe, along with expectations that already elevated raw material and energy prices will continue to rise into the New Year, leave us little choice but to implement this increase," said Phil Woolley, Director - Paper Europe. Sonoco-Alcore S.a.r.l. is wholly-owned by Sonoco (NYSE:SON) and operates 29 tubes and cores plants and four paperboard mills in Europe. Contact: Roger Schrum +843/339-6018 email@example.com This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corpor
Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors11.12.2017 14:15 | Pressemelding
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the election of William F. Doyle and Hans Peter Hasler to the Board of Directors of the Company. "Bill Doyle and Hans Peter Hasler bring distinguished leadership backgrounds and complementary sets of expertise to Minerva's Board of Directors," said Dr. Fouzia Laghrissi-Thode, Board member and chairperson of the search committee at Minerva. "Their bio-pharma industry-specific experience, which encompasses strategic development, partnering, licensing, product launches, marketing and commercialization, will benefit Minerva as the foundation is laid for the commercialization of the Company's products currently in advanced clinical development. We look forward to Bill's and Hans's entrepreneurial and operational perspectives on how Minerva can b
Sabina Gold & Silver Announces Commencement of the Review of its Water License Applications for the Back River Project11.12.2017 13:30 | Pressemelding
VANCOUVER, British Columbia, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Sabina Gold & Silver Corp (TSX:SBB.T), ("Sabina" or the "Company") is pleased to announce that the Nunavut Water Board (NWB) has commenced public review of the Type A and Type B water license applications related to initial development, mine construction and operation of the Back River Project (the "Project" or "Back River"). As announced on December 6, 2017, the Minister of Indigenous and Northern Affairs Canada, on behalf of the five responsible federal Ministers, accepted Nunavut Impact Review Board's recommendation for the Project to proceed to the regulatory and licensing phase. The NIRB has advised that the final Project Certificate will be issued on or before January 4, 2018. The Type B water license would enable Sabina to commence certain initial pre-development activities in 2018 including onsite construction of service roads and laydown pads, and the mobilization of fuel, supplies and equipment at t
Standard Lithium Provides Development Update on California Lithium Project11.12.2017 11:00 | Pressemelding
VANCOUVER, British Columbia, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSX-V:SLL) (FRA:S5L) (OTCQX:STLHF) is pleased to provide an update on the development work taking place at the Company's California Lithium Project; comprising the Bristol Dry Lake and the Cadiz Dry Lake lithium brine properties located in the Mojave Desert, California. A total of six new separate evaporation ponds have been installed on the Bristol Dry Lake Property to further assess the role that short-duration passive solar evaporation may play in processing the lithium brines encountered at the project. Previous work demonstrated that, owing to extremely high evaporation rates in the project area, it is possible to concentrate brines from initial lithium concentrations of 146 mg/L to concentrations of 686 mg/L in approximately 7 weeks (note, this average lithium concentration was previously reported as 556 mg/L in news release dated 10th Oct 2017,
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom